NASD · Healthcare · Medical Devices · USA
Apyx Medical Corp is a micro cap company (market value under $300 million) in the Medical Devices industry.
Apyx Medical is a surgical aesthetics company offering Helium Plasma Platform Technology products including Renuvion and J-Plasma for cosmetic and hospital surgical markets, plus the AYON body contouring system. The company serves cosmetic surgeons through a direct sales force and international distributors, and manufactures products in Florida and Bulgaria.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Apyx Medical Corp stock.
Overvalued: intrinsic value $1.71 per share, market price $2.56, margin of safety -49.6% (as of 2026-11-17).
A 1.3x revenue multiple, discounted for its losses, values the shares at $1.71; the price of $2.56 is 50% above that value.
1 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
29 more in this industry show a wider margin of safety.
APYX is overvalued (as of the 2026-11-17 close). A 1.3x revenue multiple, discounted for its losses, values the shares at $1.71; the price of $2.56 is 50% above that value.
$1.71 per share (as of the 2026-11-17 close), against a market price of $2.56. That is a margin of safety of -49.6%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.